Role of Lugol solution before total thyroidectomy for Graves’ disease: randomized clinical trial
Schiavone D, Crimì F, Cabrelle G, Pennelli G, Sacchi D, Mian C et al.
Br J Surg 2024; 111: znae196.
In this study that included 56 patients, preoperative use of Lugol’s significantly reduced T3 and T4 levels, but had no effect on clinical outcomes, including blood loss (80.5 versus 94ml with no Lugols’s) and duration of surgery.
Comment: Is the trial large enough to wave goodbye to Lugol’s?
18 September 2024
Read paperAcademy
Part of the charitable activity of the Foundation, BJS Academy is an online educational resource for current and future surgeons.
The Academy is comprised of five distinct sections: Continuing surgical education, Young BJS, Cutting edge, Scientific surgery and Surgical news. Although the majority of this is open access, additional content is available to BJS subscribers and strategic partners.
